The legal battle over abortion pills escalated to the Supreme Court on Saturday, as two manufacturers of mifepristone filed an emergency request warning a lower court ruling is already causing "immediate confusion and upheaval" across the country.
Danco Laboratories is asking the high court to quickly block a 5th U.S. Circuit Court of Appeals decision that blocked mail-order access and reinstated in-person requirements for the drug, arguing the ruling is disrupting access and creating nationwide uncertainty about legality.
A second manufacturer, GenBioPro, which produces a generic version of mifepristone, also filed an emergency request Saturday with the Supreme Court raising similar concerns.
Read Full Article Here
